Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Lexicon Pharmaceuticals, Inc.    LXRX   US5288721047

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/26/2014 08/27/2014 08/28/2014 08/29/2014 09/02/2014 Date
1.53(c) 1.5(c) 1.5(c) 1.52(c) 1.51(c) Last
749 053 856 115 540 788 472 160 716 573 Volume
+2.00% -1.96% 0.00% +1.33% -0.66% Change
More quotes
Company
Lexicon Pharmaceuticals, Inc. engages in discovery and development of breakthrough treatments for human disease. The company primarily focuses on the discovery of the functions and pharmaceutical utility of genes and the use of those gene function discoveries in the discovery and development of... 
Sector
Biotechnology & Medical Research
Calendar
09/09 | 10:35amPresentation
Surperformance© rating of Lexicon Pharmaceuticals, I
Trading Rating : Investor Rating :
More about the company
Chart LEXICON PHARMACEUTICALS, I
Duration : Period :
Lexicon Pharmaceuticals, I Technical Analysis Chart | LXRX | US5288721047 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 1,33 M
EBIT 2014 -105 M
Net income 2014 -106 M
Debt 2014 5,00 M
Yield 2014 -
Sales 2015 21,9 M
EBIT 2015 -93,2 M
Net income 2015 -92,9 M
Debt 2015 75,0 M
Yield 2015 -
PER 2014 -
PER 2015
EV / Sales 2014 593x
EV / Sales 2015 39,1x
Capitalization 783 M
More Financials
Latest news on LEXICON PHARMACEUTICALS, I
08/13 LEXICON PHARMACEUTICALS : To Report Second Quarter 2014 Financial Results On Aug..
08/13 LEXICON PHARMACEUTICALS : To Present At The 2014 Wedbush Life Sciences Managemen..
08/11 LEXICON PHARMACEUTICALS : to Present at the 2014 Wedbush Life Sciences Managemen..
08/08 LEXICON PHARMACEUTICALS : To Present At The 2014 Wedbush Life Sciences Managemen..
08/07 LEXICON PHARMACEUTICALS : DE Management's Discussion and Analysis of Financial C..
08/07 LEXICON PHARMACEUTICALS : DE : Results of Operations and Financial Condition, Fi..
08/07 LEXICON PHARMACEUTICALS : Provides Clinical Pipeline Update And Reports 2014 Sec..
08/05 LEXICON PHARMACEUTICALS : To Report Second Quarter 2014 Financial Results On Aug..
07/16 LEXICON PHARMACEUTICALS : Announces Appointment of Lonnel Coats as President and..
07/16 LEXICON PHARMACEUTICALS : And JDRF Collaborate For Phase 2 Clinical Trial Of LX4..
07/10 LEXICON PHARMACEUTICALS : and JDRF Collaborate for Phase 2 Clinical Trial of LX4..
07/09 LEXICON PHARMACEUTICALS : And JDRF Collaborate For Phase 2 Clinical Trial Of LX4..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Technical analysis
Income Statement Evolution
Lexicon Pharmaceuticals, I : Income Statement Evolution
More Financials
EPS Revisions
Lexicon Pharmaceuticals, I : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF